Geri
Simcere Pharmaceutical Group Limited (02096.HK) Fiyatı
02096.HK Hisse Senedi Fiyat Grafiği
SIMCERE PHARMA (02096.HK)
Simcere Pharmaceutical Group Limited
HK$0
0%
$0
Piyasa Kapalı: Jan 30, 16:00:00 HKT
Henüz Veri YokFollow-Up Questions
Simcere Pharmaceutical Group Limited'in temel mali tabloları nelerdir?
02096.HK'ün temel finansal oranları nelerdir?
Simcere Pharmaceutical Group Limited'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Simcere Pharmaceutical Group Limited kârlı mı?
Simcere Pharmaceutical Group Limited'in herhangi bir yükümlülüğü var mı?
Simcere Pharmaceutical Group Limited'in tedavüldeki hisse sayısı kaçtır?
Önemli İstatistikler
Önceki Kapanış
--
Açılış fiyatı
--
Günün Aralığı
-
52 haftalık aralık
-
İşlem hacmi
--
Ort.Hacim
8.2M
EPS (TTM)
0.40
Dividend yield
--
Piyasa Değeri
--
SIMCERE PHARMA nedir?
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 6,815 full-time employees. The company went IPO on 2020-10-27. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved